Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
Biol Psychiatry March 1, 2002 DOI: 10.1016/s0006-3223(01)01242-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Healthy volunteers |
| Measures | Mismatch negativity (MMN) |
| Key findings | Baseline MMN amplitude predicted the severity of psychotic experiences induced by ketamine, indicating that MMN may be a biomarker for psychosis vulnerability. |
Abstract
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.